Physician profile

Joseph Thomas Mahon

Urology · Edina, MN

NPI 1295171072

$85,935.48

in general payments reported to CMS, 2019-2025

45 companies · $3,378 in 2025

The $3,378 reported for 2025 was more than what 88% of Urology providers received nationally (typical 2025 total: $631).

See the full distribution for Urology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$12,176.25
Food and Beverage$5,875.62

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $65,319.79 2019-2025 Ams 700, Ams 700 Cxr Rte Kit, Rezum Generator
Coloplast Corp $15,382.06 2019-2025 Titan, Speedicath, Altis
Axonics, INC. $735.55 2020-2024 Axonics
Srs Medical Systems, INC. $542.61 2021-2023 Urocuff
Dendreon Pharmaceuticals LLC $524.10 2019-2024 Provenge
Procept Biorobotics Corporation $473.54 2023-2025 Aquabeam Robotic System, Aquabeam System
Olympus America INC. $310.92 2021-2025 Itind System
Antares Pharma, INC. $266.73 2019-2024 Xyosted, Tlando, Nocdurna
Teleflex LLC $171.19 2022-2025 Barrigel
Halozyme INC $169.32 2023
Janssen Biotech, INC. $167.86 2019-2024 Erleada
Conmed Corporation $138.08 2023 Airseal
Medtronic, INC. $136.63 2022-2024 Interstim
Astellas Pharma US INC $135.73 2019-2025 Xtandi
Agiliti Surgical, INC. $129.61 2023 Sonablate
Show all 45 companies
CompanyGeneral paymentsYearsTop products
Laborie Medical Technologies Corp. $125.47 2025
Pacira Pharmaceuticals Incorporated $122.00 2022
Progenics Pharmaceuticals, INC. $89.83 2021-2024 Pylarify
180 Medical, INC. $82.45 2021-2024
Abbvie INC. $67.05 2021-2025
Tempus Ai, INC $66.87 2024-2025 Xt Cdx
Convatec INC. $57.71 2021-2023
Accord Healthcare, INC. $54.96 2022-2024
Hitachi Healthcare Americas Corp. $52.33 2019
Caris Mpi, INC. $50.90 2025 Mi Cancer Seek
Astrazeneca Pharmaceuticals LP $45.21 2023-2024 Lynparza
Endo Pharmaceuticals INC. $44.71 2023 Xiaflex
Tolmar, INC. $43.17 2023-2024
Galvanize Therapeutics, INC $41.79 2025 Aliya System
Myovant Sciences INC. $39.07 2021
Urogen Pharma, INC. $35.17 2024-2025
Novartis Pharmaceuticals Corporation $34.18 2024-2025
Bayer Healthcare Pharmaceuticals INC. $33.91 2020-2025
Telix Pharmaceuticals $30.54 2023 Illuccix
Bluewind Medical $30.19 2024 Revi
Abc Home Medical Supply, INC. $29.28 2022-2025
Innovation Technologies INC $27.48 2025 Irrisept
Immunitybio, INC. $20.12 2025
Sumitomo Pharma America, INC. $18.47 2023 Orgovyx
Amgen INC. $18.46 2025 Tavneos
Neotract INC. $14.78 2019
Sun Pharmaceutical Industries INC. $14.61 2024
Blue Earth Diagnostics $14.45 2025 Posluma
Tolmar Pharmaceuticals, INC. $13.75 2019
Ambu INC. $12.85 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Joseph Thomas Mahon

$85,935.48

in general payments reported 2019-2025

Years
2019-2025
Top company
Boston Scientific Corporation
Context
The $3,378 reported for 2025 was more than what 88% of Urology providers received nationally (typical 2025 total: $631).

https://glasscript.com/doctor/4736664/joseph-thomas-mahon

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.